title: Cytomegalovirus infection during OKT3 treatment for renal allograft rejection.
authors.affiliation: Department of Surgery, Leicester General Hospital, United Kingdom.
authors.forename: J D
authors.initials: JD
authors.lastname: Morgan
authors.forename: T
authors.initials: T
authors.lastname: Horsburgh
authors.forename: A
authors.initials: A
authors.lastname: Simpson
authors.forename: P K
authors.initials: PK
authors.lastname: Donnelly
authors.forename: P S
authors.initials: PS
authors.lastname: Veitch
authors.forename: P R
authors.initials: PR
authors.lastname: Bell
mesh_terms: D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000276:immunology* / Q000635:transmission; D004305:Dose-Response Relationship, Drug; D015774:Ganciclovir / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000008:administration & dosage* / Q000009:adverse effects; D009894:Opportunistic Infections / Q000276:immunology*; D011183:Postoperative Complications / Q000276:immunology / Q000628:therapy*; D014019:Tissue Donors
chemical_list: D016853:Muromonab-CD3; D015774:Ganciclovir